George Georges

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

J. Christian Virchow, Piotr Kuna, Pierluigi Paggiaro et al. · The Lancet · 2019 · 195 citations · Full text

Asthma, Allergy, Clinical Trials +7

Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study

Allen P. Kaplan, Sheldon L. Spector, Suzanne Meeves et al. · Annals of Allergy Asthma & Immunology · 2005 · 51 citations

Once-daily Fexofenadine Treatment, Allergy Medicine, Clinical Dermatology +5

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis

Frank C. Hampel, Paul H. Ratner, Lyndon E. Mansfield et al. · Annals of Allergy Asthma & Immunology · 2003 · 47 citations

Asthma, Allergy, Medicine +9

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study

Omar S. Usmani, S. Baldi, Simon Warren et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2022 · 44 citations · Full text

<p>Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations</p>

Omar S. Usmani, Nicola Scichilone, Benjamin Mignot et al. · International Journal of COPD · 2020 · 43 citations · Full text